Speaker | Talk Title | |
---|---|---|
Dr. Khalid Shah Harvard Medical School, USA |
Gene Edited and Engineered Tumor cells:A New Immunotherapeutic Approach for Cancer | |
Dr. Rajiv Khanna QIMR Berghofer Medical Research Institute, Australia |
Cellular Immunotherapies for Virus-associated Cancers and Post-transplant Infectious Complications | |
Dr. Avery D. Posey Perelman School of Medicine, University of Pennsylvania, USA |
Next-generation CARS- Targeting Solid Tumours taking into consideration the Tumour Microenvironment |
Speaker | Talk Title | |
---|---|---|
Dr. Steven Highfill National Cancer Institute, USA |
Novel Manufacturing Process: CAR-T cell expansion platforms yield distinct T cell differentiation states | |
Mr. Srinidhi Deshpande Cytiva, CCRM, Canada |
Buy vs Build Manufacturing - Autologous CAR T Therapy |
Speaker | Talk Title | |
---|---|---|
Dr. Hasmukh Jain Tata Memorial Hospital, Mumbai, India |
The Landscape of CD19-directed CAR T Therapies for B-Lymphomas in Adults | |
Dr. Carlos Fernandez de Larrea University of Barcelona, Barcelona, Spain |
CAR-T Cells in Multiple Myeloma & Spain's Academic Model for CAR-T Development | |
Dr. Nirali Shah Cancer Institute, USA |
CAR T-cells for Myeloid Malignancies: So Near & Yet So Far | |
Dr. Stephan A. Grupp Children's Hospital of Philadelphia, USA |
Building Better CART Therapies - Reflections of emergent challenges over a decade of CAR T cell therapy | |
Dr. Ajay Vora University of Sheffield, UK |
Replacing chemotherapy with immune therapy in children and young persons with ALL | |
Dr. Kevin Hay Terry Terry Fox Laboratory, Canada |
First in Canada CAR-T Cell Therapy-Building Low Cost and Equitable Treatment Capacity |
Speaker | Talk Title | |
---|---|---|
Dr. Gaurav Chatterjee ACTREC, Mumbai, India |
Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis | |
Dr. Nishant Jindal ACTREC, Mumbai, India |
Third Party Virus Specific T-Cells Post Allogenic Transplant | |
Dr. Swaminathan lyer MD Anderson Cancer Center, USA |
Off the shelf CAR-T approaches for Lymphoma |
Speaker | Talk Title | |
---|---|---|
Dr. Peter Marks National Cancer Institute, USA |
Regulatory Advice to Guide the Development of the Next Wave of Cell Therapies |
International Speaker | Talk Title | |
---|---|---|
Dr. Anand Govindaluri Moderator ImmunoACT |
Catalyzing Investments in Cell & Gene therapy Industry |
International Speaker | Talk Title | |
---|---|---|
Ms. Shalini Jatia Moderator ImmunoACT |
Fire Side Panel Discussion with leading Oncologists, Patient Solution Focused Agencies and Patient Advocate groups |